Dr. Patrick Soon-Shiong

By Jonah Comstock May 9, 2016
NantHealth, the digital health wing of Dr. Patrick Soon-Shiong's NantWorks portfolio of companies, has registered for an initial public offering. The filing was for a $92 million IPO, which seems quite low for a company that regularly secured nine-figure investments, but is likely just a placeholder. NantHealth has raised at least $680 million from investors that include Allscripts, Blackberry,...
By Aditi Pai December 8, 2014
BlackBerry announced plans to add a genome browser app, powered by NantHealth, to its Blackberry Passport smartphone next year. The company will demo this service, called the NantOmics Cancer Genome Browser, at the Consumer Electronics Show in January and will preload the service on select BlackBerry Passport phones in early 2015. NantOmics will provide oncologists access to their patients'...
By Aditi Pai May 19, 2014
NantHealth raised $135 million from three investors, according to an SEC filing. The amount almost certainly includes the $100 million NantHealth raised last month from the Kuwait Investment Authority (KIA), that country's sovereign investment fund, as well as the investment Blackberry contributed in April 2014. The SEC filing notes that there were three investors in the round. This latest round...
By Brian Dolan April 15, 2014
Waterloo, Ontario-based BlackBerry (formerly known as Research In Motion) announced this week an investment in Dr. Patrick Soon-Shiong's digital health rollup NantHealth, which boasts that about 250 hospitals are now using its cloud-based, clinical decision support platform. The dollar amount of the investment was not disclosed. BlackBerry and NantHealth haven't yet finalized the specific details...
By Jonah Comstock November 21, 2013
A non-health related demo of Fluential's software. Billionaire doctor Patrick Soon-Shiong's Nant Health is making a big investment in voice interfaces for healthcare. The company is investing $8 million in Fluential, a stealthy but longstanding company working on "of speech optimization and deep language understanding tools for mobile devices, wearables and consumer 'personal assistant'...
By Brian Dolan July 20, 2011
PHR provider Dossia unveiled the latest version of its Dossia Health Manager software this week. It will be available to existing customers in the third quarter of 2011. According to the non-profit consortium, the Health Manager now "integrates game and social dynamics, incentives and messaging to foster sustained user engagement and behavior change, thereby offering long-term value to employers...
By Brian Dolan July 11, 2011
The FDA has cleared UK-based Toumaz Limited's Sensium Digital Plaster with a 510(k). The device is a small, low power body-worn sensor that continuously monitors vital signs, including temperature, heart rate and respiration rate. Toumaz also announced the formation of a joint venture with Dr Patrick Soon-Shiong's California Capital Equity (CCE). The JV will be called Toumaz US and will sell and...
By Brian Dolan February 14, 2011
Dr. Patrick Soon-Shiong, the executive director of the UCLA Wireless Health Institute and recent acquirer of GlowCaps maker Vitality, has made a strategic investment in Toumaz, which is developing low cost, ultra-low power wireless technologies for a number of verticals including medical monitoring and internet-connected consumer devices. The wireless technology that Toumaz is building is called...
By Brian Dolan February 2, 2011
Pharma entrepreneur and billionaire Dr Patrick Soon-Shiong has acquired Vitality, the company that developed GlowCaps. Vitality CEO David Rose stated in the company press release that while the financial terms of the acquisition have not been disclosed, Vitality's investors achieved a ten-fold return on their investments. In 2009 InformationWeek reported that the company had raised about $4...
By Brian Dolan January 13, 2010
The FDA recently approved MediSens Wireless' wireless body monitoring system, which assesses muscle and neuromotor functions in the upper extremities, for its first phase of clinical trials. MediSens' Clinical Movement Assessment System (CMAS) could be used by health care professionals working in physical medicine and rehabilitation, neurology, orthopedics and physical and occupational therapy....

Editor's Pick